Report cover image

Global Oral Transmucosal Drugs Market Size Study, by Product Type (Tablets, Films, Liquid & Spray, Other Product Types), by Route of Administration (Sublingual Mucosa, Buccal Mucosa, Other Routes of Administration), by Indication (Opioid Dependence, Nause

Publisher Bizwit Research & Consulting
Published Aug 20, 2024
Length 285 Pages
SKU # BIZW19091625

Description

Global Oral Transmucosal Drugs Market Size Study, by Product Type (Tablets, Films, Liquid & Spray, Other Product Types), by Route of Administration (Sublingual Mucosa, Buccal Mucosa, Other Routes of Administration), by Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, Other Indications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2032


Global Oral Transmucosal Drugs Market is valued at approximately USD 34.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.71% over the forecast period 2024-2032. Oral transmucosal drugs are a unique class of medications administered through the mucous membranes in the mouth, such as the buccal or sublingual areas. This method of drug delivery ensures that the medication is directly absorbed into the bloodstream, bypassing the gastrointestinal tract and liver, which enhances bioavailability and provides a faster onset of action. Such drugs are often employed in pain management, hormone replacement therapy, and conditions requiring rapid systemic effects. They present a non-invasive alternative to injections and traditional oral tablets.

The Global Oral Transmucosal Drugs Market growth is propelled by the rising demand for oral transmucosal drugs, driven by the increasing prevalence of chronic diseases. Innovations in drug delivery technologies further fuel market expansion, making these medications more effective and accessible. Moreover, rising investments in pharmaceutical R&D are anticipated to create lucrative opportunities for the market. However, the market faces challenges such as stringent regulatory requirements for drug approval and high costs associated with research and development activities.

The key regions considered for the Global Oral Transmucosal Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the oral transmucosal drugs market, holding the largest market share. This dominance is expected to continue throughout the forecast period, supported by a favorable regulatory environment that encourages pharmaceutical companies to invest in research and development of these medications, thereby fueling demand. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

Aquestive Therapeutics, Inc

Jazz Pharmaceuticals, plc.

Pfizer Inc.

C.L.Pharm Co., Ltd.

Cure Pharmaceutical

IntelGenx Technologies Corp

NAL Pharma

Novartis AG

Teva Pharmaceutical Industries Limited

ZIM Laboratories Limited

The detailed segments and sub-segment of the market are explained below:

By Product Type:
• Tablets
• Films
• Liquid & Spray
• Other Product Types

By Route of Administration:
• Sublingual Mucosa
• Buccal Mucosa
• Other Routes of Administration

By Indication:
• Opioid Dependence
• Nausea and Vomiting
• Erectile Dysfunction
• Neurological Disorders
• Other Indications

By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Oral Transmucosal Drugs Market Executive Summary
1.1. Global Oral Transmucosal Drugs Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Route of Administration
1.3.3. By Indication
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Oral Transmucosal Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Oral Transmucosal Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Rising Demand for Oral Transmucosal Drugs
3.1.2. Advancements in Drug Delivery Technologies
3.1.3. Increasing Prevalence of Chronic Diseases
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements for Drug Approval and Commercialization
3.2.2. High Cost Associated with Research and Development Activities
3.3. Market Opportunities
3.3.1. Favorable Regulatory Environments
3.3.2. Investments in Pharmaceutical R&D
3.3.3. Emerging Markets in various economies
Chapter 4. Global Oral Transmucosal Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Oral Transmucosal Drugs Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Oral Transmucosal Drugs Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Tablets
5.2.2. Films
5.2.3. Liquid & Spray
5.2.4. Other Product Types
Chapter 6. Global Oral Transmucosal Drugs Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Oral Transmucosal Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Sublingual Mucosa
6.2.2. Buccal Mucosa
6.2.3. Other Routes of Administration
Chapter 7. Global Oral Transmucosal Drugs Market Size & Forecasts by Indication 2022-2032
7.1. Segment Dashboard
7.2. Global Oral Transmucosal Drugs Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Opioid Dependence
7.2.2. Nausea and Vomiting
7.2.3. Erectile Dysfunction
7.2.4. Neurological Disorders
7.2.5. Other Indications
Chapter 8. Global Oral Transmucosal Drugs Market Size & Forecasts by Distribution Channel 2022-2032
8.1. Segment Dashboard
8.2. Global Oral Transmucosal Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Global Oral Transmucosal Drugs Market Size & Forecasts by Region 2022-2032
9.1. North America Oral Transmucosal Drugs Market
9.1.1. U.S. Oral Transmucosal Drugs Market
9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
9.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
9.1.1.3. Indication breakdown size & forecasts, 2022-2032
9.1.1.4. Distribution Channel breakdown size & forecasts, 2022-2032
9.1.2. Canada Oral Transmucosal Drugs Market
9.2. Europe Oral Transmucosal Drugs Market
9.2.1. U.K. Oral Transmucosal Drugs Market
9.2.2. Germany Oral Transmucosal Drugs Market
9.2.3. France Oral Transmucosal Drugs Market
9.2.4. Spain Oral Transmucosal Drugs Market
9.2.5. Italy Oral Transmucosal Drugs Market
9.2.6. Rest of Europe Oral Transmucosal Drugs Market
9.3. Asia-Pacific Oral Transmucosal Drugs Market
9.3.1. China Oral Transmucosal Drugs Market
9.3.2. India Oral Transmucosal Drugs Market
9.3.3. Japan Oral Transmucosal Drugs Market
9.3.4. Australia Oral Transmucosal Drugs Market
9.3.5. South Korea Oral Transmucosal Drugs Market
9.3.6. Rest of Asia Pacific Oral Transmucosal Drugs Market
9.4. Latin America Oral Transmucosal Drugs Market
9.4.1. Brazil Oral Transmucosal Drugs Market
9.4.2. Mexico Oral Transmucosal Drugs Market
9.4.3. Rest of Latin America Oral Transmucosal Drugs Market
9.5. Middle East & Africa Oral Transmucosal Drugs Market
9.5.1. Saudi Arabia Oral Transmucosal Drugs Market
9.5.2. South Africa Oral Transmucosal Drugs Market
9.5.3. Rest of Middle East & Africa Oral Transmucosal Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Aquestive Therapeutics, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Jazz Pharmaceuticals, plc.
10.3.3. Pfizer Inc.
10.3.4. C.L.Pharm Co., Ltd.
10.3.5. Cure Pharmaceutical.
10.3.6. IntelGenx Technologies Corp.
10.3.7. NAL Pharma
10.3.8. Novartis AG
10.3.9. Teva Pharmaceutical Industries Limited.
10.3.10. ZIM Laboratories Limited
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Oral Transmucosal Drugs Market, report scope
TABLE 2. Global Oral Transmucosal Drugs Market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Oral Transmucosal Drugs Market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 4. Global Oral Transmucosal Drugs Market estimates & forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 5. Global Oral Transmucosal Drugs Market estimates & forecasts by Indication 2022-2032 (USD Billion)
TABLE 6. Global Oral Transmucosal Drugs Market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 7. Global Oral Transmucosal Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Oral Transmucosal Drugs Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. U.S. Oral Transmucosal Drugs Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 11. Canada Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Canada Oral Transmucosal Drugs Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 13. UK Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Germany Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. France Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. Spain Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 17. Italy Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 18. Rest of Europe Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. China Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 20. India Oral Transmucosal Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
...
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable
List of Figures
FIGURE 1. Global Oral Transmucosal Drugs Market, research methodology
FIGURE 2. Global Oral Transmucosal Drugs Market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Oral Transmucosal Drugs Market, key trends 2023
FIGURE 5. Global Oral Transmucosal Drugs Market, growth prospects 2022-2032
FIGURE 6. Global Oral Transmucosal Drugs Market, porters 5 force model
FIGURE 7. Global Oral Transmucosal Drugs Market, PESTEL analysis
FIGURE 8. Global Oral Transmucosal Drugs Market, value chain analysis
FIGURE 9. Global Oral Transmucosal Drugs Market by segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Oral Transmucosal Drugs Market by segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Oral Transmucosal Drugs Market by segment, 2022 & 2032 (USD Billion)
FIGURE 12. Global Oral Transmucosal Drugs Market by segment, 2022 & 2032 (USD Billion)
FIGURE 13. Global Oral Transmucosal Drugs Market by segment, 2022 & 2032 (USD Billion)
FIGURE 14. Global Oral Transmucosal Drugs Market, regional snapshot 2022 & 2032
FIGURE 15. North America Oral Transmucosal Drugs Market 2022 & 2032 (USD Billion)
FIGURE 16. Europe Oral Transmucosal Drugs Market 2022 & 2032 (USD Billion)
FIGURE 17. Asia Pacific Oral Transmucosal Drugs Market 2022 & 2032 (USD Billion)
FIGURE 18. Latin America Oral Transmucosal Drugs Market 2022 & 2032 (USD Billion)
FIGURE 19. Middle East & Africa Oral Transmucosal Drugs Market 2022 & 2032 (USD Billion)
FIGURE 20. Global Oral Transmucosal Drugs Market, company market share analysis (2023)
...
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us